Search results
Getting More from IVL Technology
Author(s):
Anirban Choudhury
,
Majd B Protty
,
Hussain Hussain
,
et al
Added:
2 months ago
Article
Author(s):
Matthias Bossard
Added:
3 months ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus…
View more
Author(s):
Suzanne J Baron
Added:
3 months ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible…
View more
Intravascular Imaging on Calcium
Author(s):
Doosup Shin
,
Sarah Malik
,
Mandeep Singh
,
et al
Added:
3 months ago
Article
IVUS123 workflow for PCI
Author(s):
Simon J Walsh
,
Rafael Cavalcante
,
Kevin Croce
,
et al
Added:
2 weeks ago
Article
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
What's hot at EuroPCR 2024?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?Trials covered included:00…
View more
RotaShock Series
Author(s):
Jonathan Hinton
,
Rajesh Varma
,
Jehangir Din
,
et al
Added:
11 months ago
Article
Author(s):
Andrew Holden
Added:
9 months ago
What are the unique features of the new intravascular lithotripsy (IVL) devices addressing calcified tibial disease?Prof Andrew Holden (Auckland City Hospital, Auckland, NZ) joins us to discuss two new devices addressing calcified tibial disease, the Shockwave E8 catheter and the Shockwave Javelin catheter. Prof Holden then evaluates the safety and efficacy findings from the Disrupt PAD BTK II…
View more
Kelvin Lee
Job title: Consultant Interventional Cardiologist
Author